7575.T
7575.T
JP3754500001
JAPAN LIFELINE CO
Loading chart...

Company Profile

Japan Lifeline Co., Ltd., a medical device company, engages in manufacturing and sale of medical device in Japan. The company's cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, disposable ECG recorder, and venous vascular closure system. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts. In addition, the company offers gastrointestinal intervention products, including cholangioscope, biliary tube stent, papillary balloon dilatation catheter, self-expandable duodenal and colonic stent, endoscopic guidewire, and radiofrequency ablation systems; structural heart disease intervention products, such as radiofrequency wires and atrial septal defect closure devices; and embolic coil and aspiration catheter products. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.

Related stocks

4549.T
4549.T • Japan
EIKEN CHEMICAL CO
2,436 JPY
507.46M USD 1Y +3%
AVR
AVR • Australia
Anteris Technologies Global Cor
6.77 USD
659.01M USD 1Y +38.7%
491000.KQ
491000.KQ • South Korea
LivsMed
37,500 KRW
699.74M USD
6849.T
6849.T • Japan
NIHON KOHDEN CORP
1,643 JPY
1.66B USD 1Y -11.6%
1302.HK
1302.HK • China
LIFETECH SCI
1.35 HKD
757.09M USD 1Y -36.9%
458870.KQ
458870.KQ • South Korea
SEERS
25,850 KRW
734.2M USD 1Y +11.4%
688575.SS
688575.SS • China
SHENZHEN YHLO BIOTECH CO LTD
10.46 CNY
894.36M USD 1Y -28.1%
6523.T
6523.T • Japan
PHC HLDGS CORP
1,586 JPY
1.27B USD 1Y +63.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
27.4% p.a.
Max Drawdown (5Y)
-32.9%
Sharpe Ratio (5Y)
0.01
Beta Factor
0.23
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (27.4% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -75.9% in the extended horizon.
ende